Banaras Hindu University
23
3
3
19
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 23 trials
100.0%
+13.5% vs industry average
26%
6 trials in Phase 3/4
0%
0 of 19 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (23)
Newer Therapeutic Targets in Head and Neck Cancers
Role: lead
Addition of Everolimus to Standard of Care in Carcinoma Gallbladder
Role: lead
NGS in Gallbladder Cancer and Response to Treatment
Role: lead
of Androgen Receptor Expression in Breast Cancer With or Without BRCA Mutation
Role: lead
Addition of Aspirin to Standard of Care in Oral Cancer
Role: lead
How Well do we Feed the Critically Ill Patients
Role: collaborator
Swallowing Function in Patients With Head and Neck Cancers
Role: lead
Neoadjuvant Chemotherapy in Cervical Cancer
Role: lead
Mortality of Cancer Surgery During SARS CoV2 Pandemic
Role: lead
Cognitive Bias Modification Training in Adolescents Who Have Experienced Adversity
Role: collaborator
Trial of IIb Preserving Neck Dissection
Role: lead
Study of the Effect of Glutamine Supplementation on Chemotherapy Induced Toxicities in Breast Cancer Patients
Role: lead
Arterial Blood Gas Analysis in Laparoscopic Cholecystectomy
Role: lead
Effect of Continuous Thoracic Epidural Analgesia on Gut Motility Following Emergency Laparotomy
Role: lead
Levetiracetam Versus Sodium Valproate in Children With Refractory Generalized Convulsive Status Epilepticus
Role: lead
Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis
Role: lead
Short Course of Miltefosine and Liposomal Amphotericin B for Kala-azar
Role: lead
Combination Therapy in Indian Visceral Leishmaniasis
Role: lead
Single Infusion of Liposomal Amphotericin B in Indian Visceral Leishmaniasis
Role: lead
A Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Kala-Azar
Role: lead